What can we learn from blood granulocyte patterns in patients with asthma?

Hambleton Kirsty, Pavord Ian D.

Source: Eur Respir J 2016; 48: 976-978
Journal Issue: October
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Hambleton Kirsty, Pavord Ian D.. What can we learn from blood granulocyte patterns in patients with asthma?. Eur Respir J 2016; 48: 976-978

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD treatment choices based on blood eosinophils: are we there yet?
Source: Breathe, 15 (4) 318; 10.1183/20734735.0254-2019
Year: 2019



Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study
Source: Eur Respir J 2016; 48: 1040-1051
Year: 2016



Stability of blood eosinophils over time in patients with asthma
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


How can we better predict pulmonary blood clots in patients hospitalised for COVID-19?
Source: Eur Respir J, 56 (4) 2003092; 10.1183/13993003.03092-2020
Year: 2020



How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Peripheral blood eosinophil counts in COPD patients and its relationship with prescription of inhaled corticosteroid in real world setting in Japan.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017

Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no!
Source: Eur Respir J, 51 (5) 1800730; 10.1183/13993003.00730-2018
Year: 2018



Impact of blood eosinophil variability in asthma: a real-life population study.
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


Blood eosinophils fluctuation in asthmatics on Omalizumab-a mirror of disease outcomes improvement?
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018


Serial blood eosinophils and clinical characteristics in COPD patients without a history of asthma or atopy
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019

Association between blood eosinophil count and risk of exacerbations in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017


Patients with COPD prescribed inhaled corticosteroid in primary care – Time for re-assessment based on exacerbation rate and blood eosinophils?
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020

Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD?
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019



Association between blood eosinophil counts and risk of rehospitalization in patients with asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017



Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020


Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017



What does healthy people know about asthma?
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011


Is blood eosinophil count a biomarker for chronic obstructive pulmonary disease in a real-world clinical setting? Predictive property and longitudinal stability in Japanese patients.
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021



Can blood eosinophils predict sputum eosinophils in stable COPD?
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015